Topics

Glioblastoma | Treatment | Chemotherapy | Temozolomide | Tumor treating fields

Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Tumor treating fields

Goldlust SA, Singer S, Cappello LA, AlMekkawi AK, Lee KD, Ingenito AC, Lewis BE, Nyirenda T, Azmi H, Kaptain GJ.
Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma.
Neurooncol Adv. 2024 Jul 29;6(1):vdae129. doi: 10.1093/noajnl/vdae129. PMID: 39211521. Interventional study.ˍ

Chen D, Le SB, Ghiaseddin AP, Manektalia H, Li M, O'Dell A, Rahman M, Tran DD.
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study.
Med. 2025 Jun 3:100708. doi: 10.1016/j.medj.2025.100708. PMID: 40466642. Interventional study. ˍ